Key Points for Decision Makers {#FPar1}
==============================

The analysis reveals strong within-country heterogeneity among the efficiencies of five different aspects of the health care system.The results for several aspects of health care systems highlight potential improvements in specific areas of these systems.Benchmark countries with highly efficient health care systems often present systems with high output and mediocre input or with mediocre output and low input, meaning that policymakers can select a role-model system according to their preferences.

Introduction {#Sec1}
============

Providing health care is an important service of any country's government, and the efficiency of the health care system is a recurring and relevant key topic in health policy discussions. According to the Global Health Expenditure database of the World Health Organization (WHO), health expenditure as a percentage of GDP has increased strongly in recent years. Due to demographic changes, we can assume that this trend will continue in the coming decades. Hence, it is important to evaluate the efficiency of the health care systems of various countries. Efficiency analysis can point to potential input reductions or potential output increases. Therefore, benchmarking health care systems is important for identifying best practices and inefficient health care systems.

The contribution to the existing literature provided by the present paper is threefold. Firstly, we provide a theoretical discussion of ideal-typical measurements of health care efficiency, which serves as a yardstick when dealing with the severe data limitations that are often present when performing empirical analysis in this field. Secondly, because an all-encompassing analysis that includes inputs and outputs of very different aspects of the health care system can lead to compensating effects that hide specific strengths and weaknesses of that system, we perform five individual efficiency analyses, each focusing on different aspects of health care systems, thus avoiding any compensating effects. For example, Retzlaff-Roberts et al. \[[@CR1]\] have shown that countries may be efficient at one aspect of health care (e.g., at improving life expectancy) but inefficient at other aspects (e.g., at reducing mortality). Thirdly, in addition to DEA efficiency scores, we provide a measure of relative productivity based on average prices, which prevents both the strengths of some health care systems from being exaggerated and unrealistic zero weights from being applied to specific inputs or outputs.

We investigate health care system efficiency at the country level based on OECD health data and apply data envelopment analysis (DEA). As the results and the scientific value of health care efficiency analysis depend crucially on the appropriateness of the inputs and outputs used, we discuss input and output choices in detail. In an empirical efficiency analysis, we consider several aspects of health care systems and conduct five partial analyses focusing on medical inputs and surgery provision; medical inputs and mortality prevention; lifestyle and life expectancy from birth; income, health expenditure, and life expectancy from birth; and relative expenditure, income inequality, and life expectancy from birth. We use data from 16--30 OECD countries in these five partial analyses.

For each country, we observed strong variations in efficiency across the five analyses; some countries are efficient at producing a particular health care output but very inefficient at producing other outputs. This emphasizes the value of disaggregated analysis, as one all-encompassing analysis including many inputs and outputs from different aspects of a health care system would mask specific inefficiencies in that system.

Furthermore, we find that different countries have achieved high efficiency in rather different ways; e.g., some health care systems yield low output but are highly efficient because only very low input quantities are invested in the first place. In terms of policy recommendations, the benchmark health care system will of course depend on the preferences of the country that is choosing a health care system. These detailed results enable countries to prioritize and to focus on improving specific aspects of health production. As some inputs cannot be changed in the short term (e.g., health-related behavior), focusing on output improvements may be a more relevant approach for policymakers.

This paper is organized as follows: Sect. [2](#Sec2){ref-type="sec"} contains some general methodological considerations. Section [3](#Sec5){ref-type="sec"} provides a brief overview of the relevant literature on international comparisons of health care system efficiency. In Sect. [4](#Sec6){ref-type="sec"}, we discuss measurement issues, input and output selection, the database, and the methodology used. Section [5](#Sec15){ref-type="sec"} contains the empirical results from the five separate analyses and a synopsis. Section [6](#Sec22){ref-type="sec"} draws conclusions and contains policy implications.

General Methodological Considerations {#Sec2}
=====================================

Data envelopment analysis is a very popular method of obtaining efficiency scores for decision-making units (DMUs) in general and for countries' health care systems in our case. Its charm is its simplicity, as different health care systems are compared to the most efficient health care system, which most often is a synthetic health care system obtained as a linear combination of the observed health care systems of countries belonging to the reference set. Furthermore, the method is nonparametric, meaning that neither questionable assumptions about functional relations between inputs and outputs nor distributional assumptions need to be made.

Productivity, Relative Efficiency, and the Weighting Scheme {#Sec3}
-----------------------------------------------------------

The productivity of a health care system is the ratio of the aggregated health output to the aggregated health input,$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} \frac{\text {Health\, output}}{\text {Health \,input}}. \end{aligned}$$\end{document}$$The aim of efficient production is to maximize the output given a certain amount of input or to minimize the input given a certain amount of output. In our empirical efficiency analysis, we only consider the concept of relative efficiency. That is we simply compare the actual input amounts with lower hypothetical inputs of a (potentially synthetic) efficient health system given the actual output amounts. Hence, health care systems regarded as efficient serve as a benchmark when calculating the relative efficiency of the health care system being analyzed.

Note that a simple comparison of output relative to input is only possible if we sum the multiple different inputs for a health care system into a single input measure and the multiple different outputs of the system into a single output measure. As the quantities of different goods cannot be summed, weights must be used when aggregating them.
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                \begin{document}$$k\cdot v_{i}$$\end{document}$ alters the productivities but not the resulting relative efficiency measure, as the scaling factors cancel out. Hence, the resulting efficiency measure depends only on the relative input and output prices chosen.

Charnes--Cooper--Rhodes model {#Sec4}
-----------------------------

The ratio of weighted outputs to weighted inputs depends on the weighting scheme chosen. So how can we judge the efficiencies of DMUs if they depend on the weighting scheme applied? The idea behind the Charnes--Cooper--Rhodes model (CCR model) is to choose, for each DMU, the set of input and output prices that yields the maximum ratio of weighted output to weighted input, given a set of restrictions:All input and output prices must be non-negative.For all DMUs, the weighted output must not exceed the weighted input.For the DMU under consideration (*o*), we choose *v* and *u* such that its productivity $\documentclass[12pt]{minimal}
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                \begin{document}$$\theta $$\end{document}$ is maximized, under the constraint that, for all *n* DMUs, the weighted output does not exceed the weighted input and all prices are non-negative. Therefore, the problem is expressed as a linear programming problem which can be solved by means of the simplex algorithm. Obviously, the number of restrictions that have to be met here is rather large: it is the number of firms (*n*) plus the number of inputs (*m*) plus the number of outputs (*s*).
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Literature Review: International Comparisons of Health System Efficiency {#Sec5}
========================================================================

There is a body of literature in which the efficiencies of the health care systems used in various countries are compared. Most of these studies make use of OECD health data or WHO health data. The World Health Report (WHR, e.g., \[[@CR2]\]), published by the WHO, provides information on how well 191 countries are performing in relation to several health goals (improving health status and responsiveness, equality of financing) given their resources, and publishes health care system rankings. Efficiency is calculated as the ratio of observed performance to maximum performance, estimated by a fixed effects regression approach with observed inputs and outputs (see \[[@CR3]\]; for more details, see, e.g., \[[@CR4]\]). Evans et al. \[[@CR3]\] evaluated the performance of 191 WHO member states using healthy life expectancy as outcome and health expenditure per capita and average years of schooling as input measures. They found efficiency to be positively related to health expenditure. Well-performing countries included Oman, Malta, Italy, France, and San Marino. The worst-performing countries were Zimbabwe, Zambia, Namibia, Botswana, and Malawi. They concluded that countries with a good health level did not necessarily have an efficient health care system.

The WHO technique has been criticized for several reasons. Gravelle et al. \[[@CR4]\] address the measure of efficiency, the fixed effects approach, the use of logarithms, and the omission of income from the WHO analyses. They observed substantial sensitivity of the results to the model's specifications, with the country's efficiency score and rank varying considerably depending on the specifications applied. In particular, they criticize the use of within-country variation, because most of the variation occurs between countries.

Hollingsworth and Wildman \[[@CR5]\] compare parametric and nonparametric techniques \[time-varying fixed effects, DEA, Malmquist indices, stochastic frontier analysis (SFA)\] and emphasize that league tables hide valuable information on efficiency changes. In addition, they recommend that, because of their very different characteristics, OECD and non-OECD countries should be analyzed separately, and that further stratification by GDP or geographical region would also be useful.

Based on the critique of Gravelle et al. \[[@CR4]\] concerning the between-country variation, Greene \[[@CR6]\] used additional country-specific variables to account for some of the heterogeneity. Aside from health care expenditure and educational level, information on the income distribution (GDP and Gini coefficient), government effectiveness, dummy variables for tropical location and for OECD membership, population density, and an indicator relating to the allocation of health care expenditure between the private and public sector were included. The income level and the income inequality appeared to have sizeable impacts on the efficiency. Accounting for heterogeneity changed the rankings of the countries considerably.

As we use OECD data for our analysis, studies based on these data are reviewed here in more detail. Retzlaff-Roberts et al. \[[@CR1]\] estimate the technical efficiency in the use of health care resources for 27 countries by applying input- and output-oriented DEA allowing for variable returns to scale (VRS). Based on the OECD health data for the year 2000, infant mortality and life expectancy at birth are defined as outputs. Inputs are categorized into two groups; one representing the social environment of the country (school expectancy, Gini coefficient, tobacco use) and the other consisting of health-related inputs \[practicing physicians, inpatient beds, magnetic resonance imagers (MRIs), share of GDP allocated to health care\]. They find 13 countries to be efficient according to both outputs: Australia, Canada, France, Greece, Ireland, Japan, Korea, Mexico, Norway, Spain, Sweden, Turkey, and the UK. This group includes countries with good health outcomes as well as those with poor health outcomes. Six countries are efficient at producing low infant mortality only, but not at producing high life expectancy. Eight countries are inefficient with respect to both outputs: Austria, Belgium, Germany, Hungary, Netherlands, New Zealand, Switzerland, and the USA (i.e., again including countries with good and poor health outcomes). The authors conclude that a country can be technically efficient/inefficient at any level of health outcome. On average, inefficient countries could reduce infant mortality (with constant inputs) by 14.5% and increase life expectancy by only 2.1%. According to the input-oriented model, OECD countries can on average reduce inputs by 14.0 and 21.0%, respectively, without changing infant mortality and life expectancy.

Bhat \[[@CR7]\] compares 24 OECD countries and uses the number of practicing physicians, nurses, inpatient beds, and pharmaceutical consumption as inputs. Output is defined based on three proportions of the population: those aged 0--19 years, those aged 20--64 years, and those aged 65 years or older, as health expenditure varies strongly with the age structure of the population. A DEA with constant returns to scale (CRS) identifies eight countries as efficient: Denmark, Japan, Netherlands, Norway, Portugal, Sweden, Turkey, and the UK. The lowest efficiencies are found for Belgium, Iceland, and Australia. Institutional arrangements seem to have an impact on efficiency, as public-contract and public-integrated countries are more efficient than countries with a public-reimbursement system. Here, public-reimbursement systems involve the retrospective indirect payment of providers for services. In the public-contract model, providers are paid a fee directly for their services, while the public-integrated model involves direct payment through global budgets and salaries. Control of spending is highest for the public-integrated model and lowest for public-reimbursement systems.

Afonso and Aubyn \[[@CR8]\] analyze 24 OECD countries by applying two nonparametric approaches: free disposable hull (FDH) and DEA (input- and output-oriented, CRS and VRS). Just as in the study by Bhat \[[@CR7]\], the numbers of doctors, nurses, and in-patient beds serve as inputs, and, in accordance with Retzlaff-Roberts et al. \[[@CR1]\], infant survival rate and life expectancy are the health outcomes. Eight countries are found to be efficient when using the FDH and the DEA approaches: Canada, Japan, Korea, Portugal, Spain, Sweden, the UK, and the USA.

In a second paper, using a semiparametric two-stage approach, Afonso and Aubyn \[[@CR9]\] find a strong relationship between health system inefficiencies and nondiscretionary inputs. An output-oriented DEA (VRS) based on principal components of base inputs (practicing nurses, physicians, beds, MRI) and outputs (infant survival rate, life expectancy, potential years of life not lost) identifies seven countries as efficient: Canada, Finland, Japan, Korea, Spain, Sweden, and the USA. On average, countries can increase their output by 40%. In a second stage, the fact that inefficiencies are not necessarily caused by factors under the purview of the health care system is focused upon. The influence of nondiscretionary inputs on the efficiency is evaluated based on a Tobit regression. Here, the nondiscretionary inputs of GDP per capita, educational level, obesity, and tobacco consumption appear to have an impact on a country's efficiency. Correcting for environmental influences alters efficiency scores and country rankings. Countries that were poorly ranked before come closer to the efficient frontier (e.g., Denmark, Czech Republic, Hungary, Slovak Republic, and the UK), whereas the rankings of other countries decline (Canada, Sweden, USA, Japan).

A within-country comparison over time rather than a between-country comparison is conducted by Adang and Borm \[[@CR10]\]. They apply an output-oriented DEA (CRS) and a Malmquist index over the period 1995--2002 and calculate Spearman correlation coefficients to identify the relationship between changes in productivity and changes in satisfaction in health care. Inputs are the share of GDP allocated to health care, the number of practicing physicians, and tobacco use. Outputs are life expectancy at birth and infant mortality. No association between the economic performance of the health care system and the change in satisfaction with the health care system is found.

A critical study involving between-country comparisons of health production efficiency is provided by Spinks and Hollingsworth \[[@CR11]\]. Twenty-eight countries are analyzed based on OECD health data between 1995 and 2000. School expectancy years, unemployment rate, GDP per capita, and health expenditure per capita serve as inputs; life expectancy at birth serves as the health output indicator. An input-oriented DEA (VRS) analysis and Malmquist indices reveal that six countries were efficient in 1995 (Turkey, Mexico, Korea, Greece, Spain, and Japan) and eight countries were efficient in 2000 (Turkey, Mexico, Korea, Greece, Spain, Japan, Iceland, and Switzerland). Most of these efficient countries are lower ranked in GDP per capita and health expenditure per capita.

Table [1](#Tab1){ref-type="table"} provides an overview of the input and output measures used in previous research based on OECD data. An overview of the literature that has utilized the OECD data is given in Table [8](#Tab8){ref-type="table"} in the Appendix.Table 1Inputs and outputs used in the OECD dataInputsOutputsHealth expenditure per capitaLife expectancy (at birth)Percentage of health care expenditureInfant mortality (survival) ratePracticing physiciansPopulation aged 0-19 years; population aged 20-64 years; population aged 65 years and olderNursesPotential years of life not lostIn-patient bedsMRIPharmaceutical consumptionAverage years of schooling/educational levelGini coefficientGDP per capitaUnemployment rateObesityTobacco consumptionAlcohol consumption*MRI* magnetic resonance imaging, *GDP* gross domestic product

A recent study by Hsu \[[@CR12]\] uses world development indicators and global development finance data for 46 countries between 2005 and 2007 to compare the efficiency of government health expenditure between Europe and Central Asia. Health expenditure per capita is used as input for a DEA. In addition, the effects of environmental variables such as the population density, GDP per capita, hospital beds, average years of primary schooling, and a regional effect (Central Asia versus Europe). Outputs are life expectancy at birth, infant mortality rate (reciprocal), and measles immunization. Their results indicate that health spending in Europe is less efficient than that in Central Asia. Moreover, the number of hospital beds and education positively affect efficiency. Using the same data and a super slack-based measure (SBM), Hsu \[[@CR13]\] further discriminates between efficient countries in order to rank them separately.

Medeiros and Schwierz \[[@CR14]\] apply models with different combinations of inputs and outputs to assess the robustness of the results, and they conclude that efficiency scores vary strongly across efficiency models.

Summing up, we observe that a variety of input and output measures have been used in previous studies focusing on different sets of countries. However, the process by which the inputs affect the outputs is often insufficiently identified. As many studies do not include an ideal-typical characterization of the effect of health care provision on population health, the procedure used to select inputs and outputs often lacks the required theoretical underpinning. Based on this literature review, we considered it necessary to first try to characterize an ideal-typical measurement of the effects of a health system on population health, which would then serve as the foundation for operationalization under the restrictions of the OECD database.

The contribution of the present work to the existing literature is threefold. Firstly, it provides a theoretical discussion of ideal and operationalized inputs and outputs, which are important when dealing with severe data limitations. Secondly, it extends previous research by applying separate models and therefore emphasizing different objectives of the health care system. Thirdly, along with DEA efficiency scores, it provides an efficiency measure based on average prices, which prevents the strengths of particular health care systems from being overemphasized and specific poorly performing inputs or outputs from being overlooked.

Methods {#Sec6}
=======

The results and the scientific value of health care efficiency analysis depend crucially on the appropriateness of the inputs and outputs considered in the analysis. We start our discussion by formulating ideal-typical concepts (as defined by Max Weber) of inputs and outputs. These ideal-typical concepts are then contrasted with the available inputs and outputs in the OECD database.

Ideal-Typical Input Measures {#Sec7}
----------------------------

Ideally, the inputs should reflect all of the resources used by the health care system to improve the health status of the population. The inputs can be broadly classified into labor (in its different forms), materials, and the services provided by the capital stock in use. In classical economics,the total input is considered the sum of the direct labor input, the indirect labor input associated with the material consumed during the process of producing health care, and the indirect labor input associated with the portion of the capital stock that is consumed during the production process. In contrast to the classical use of labor coefficients to transform the quantities of all the different inputs into amounts of labor, other weighting schemes can be applied when aggregating the inputs.

The direct labor inputs can be broadly categorized into service by doctors, service by therapists (non-doctoral), services by nurses and care workers, services by pharmacists, and services by administrative staff. The material inputs can be further categorized according to commodity group into chemical goods, care materials, etc. The fraction of the capital stock consumed may be disaggregated into buildings, machinery (e.g., for drug production), and equipment (e.g., beds, MRIs, etc.; see Fig. [1](#Fig1){ref-type="fig"}).

Readers familiar with input--output tables could conceptualize the health system as one specific sector, which would provide the necessary information as quantities with different units of measurement. For instance, this information could be expressed in labor values, based on employment data for the relevant sectors (ignoring the issue of nonhomogeneous labor for the moment).Fig. 1Ideal-typical inputs. *MRI* magnetic resonance imaging

Ideal-Typical Output Measures {#Sec8}
-----------------------------

Starting with the idea of describing the health sector as an individual sector in the input--output analysis, the output would be the aggregated value of health goods and services produced, thereby reflecting the individual valuation of the output from the buyers' (patients') perspective. But, as most of the products of the health system are not "sold" at market prices, this concept of subjective valuation of the output is not feasible.

Going back to an ideal-typical concept of health output, three quantities may best capture the output of the health sector: the amount of pain relief, the number of additional (quality-adjusted) life years, and the increase in well-being (e.g., achieved through the use of prostheses) caused by treatment within the health system. These initially purely theoretical concepts could perhaps be evaluated by summing the values of each measure in the various subsectors: hospitals, medical practices, pharmacies, etc. Alternatively, the aggregation could be performed by summing across patient categories (e.g., acute patients, patients with chronic conditions, etc.) or population subgroups (e.g., grouped by age and sex). Hence, ideal-typical outputs could be the number of extra pain-free hours (weighted by objective pain measures) due to treatment, the sum of the extra (quality-adjusted) life years (QALYs) gained by undergoing treatment within the health system, and the increase in well-being caused by treatment (see Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Ideal-typical outputs

Obviously, the causal relation between treatments and measures often cannot be verified in practice. Furthermore, the intersubjective comparable measures of pain relief that need to be aggregated are purely theoretical, as is the calculation of additional (quality-adjusted) life years or the increase in well-being. Nevertheless, we consider this ideal-typical reasoning to be very important when judging the adequacy of available output indicators.

The OECD Database {#Sec9}
-----------------

The OECD collects health-related data on OECD countries from various data sources such as the Eurostat database, The World Bank, the Global Health Observatory data repository of the World Health Organization (WHO), and other OECD databases (OECD.Stat). These data are complemented by national databases (e.g., statistical offices, federal ministries).

The OECD health data provide information on health status (e.g., mortality, morbidity), nonmedical determinants of health (e.g., tobacco, alcohol, food consumption, obesity), health care resources (e.g., health employment and education, physical and technical resources), health care utilization (e.g., consultations, immunization, screening, hospital stay, surgical procedures, waiting times), health care quality indicators, the pharmaceutical market, expenditure on health, social protection, demographic factors (e.g., population, fertility, labor force), and economic factors (e.g., GDP, wages) (see \[[@CR15]\] for example).

Differences in the data sources, definitions, and methodologies used for variable construction affect comparability across countries. For instance, when comparing the number of practicing physicians, some countries include doctors working in administration, management, academic, and research positions, while others only include doctors who provide care directly to patients. Similarly, when comparing the number of nurses, some countries also include midwives (considered to be specialist nurses) in their figures, while others do not. When comparing surgeries, it is important to realize that classification and registration practices differ among countries. For example, some countries group data on total hip replacements and partial replacements together, while others only provide total hip replacement data. Countries also apply different rules for registering technical equipment (e.g., MRI units or CT scanners): most OECD member states include all such equipment, regardless of whether it is used in a hospital, but some countries only include equipment used in hospitals (see \[[@CR16]\]).

Moreover, a lack of standardization in health interview surveys (differences in wording and in response categories) complicates between-country comparisons. For example, the perceived health status can be retrieved from The European Union Survey on Income and Living Conditions (EU-SILC), but in this case there is no measurement standardization across OECD countries. Similarly, countries may differ in the data they provide on health-related behavior such as tobacco and alcohol consumption (see \[[@CR16]\]).

The main source of data on infant mortality in most European countries is the Eurostat database. Some of the between-country variation in infant mortality rates is probably due to differences in registering practices for premature infants. The methodology used to estimate life expectancy, data on which are again mainly retrieved from the Eurostat database, may also differ between countries. Life expectancy at birth for the whole population is calculated by the OECD Secretariat (see \[[@CR16]\]).

These limitations in between-country comparability should be kept in mind when interpreting the empirical results. Moreover, we face the problem of missing data in the OECD database, which limits empirical analyses dramatically. For our analysis, we used the OECD health data for 2012. In the rather rare cases in which entries were missing for 2012 but available for 2011, we used the 2011 values to substitute for the missing 2012 values. Only six countries could be included in all five of the partial analyses, so the number of available scores for partial analyses varied between 1 and 5 for the 34 countries.

Available Input and Output Measures and their Adequacy {#Sec10}
------------------------------------------------------

We scanned the complete available OECD health database to find the most adequate input and output indicators. Not unexpectedly, the available indicators do not remotely coincide with the ideal-typical measures discussed above. Note that we disregarded from the start all indicators with \<20 valid data (i.e., with values from \<20 countries).

### Inputs {#Sec11}

In the literature, health care expenditure is often used as an input measure. Unfortunately, however, some of this expenditure depends on the country's wage levels (for nurses, physicians, etc.) while the rest does not (e.g., expenditure on imported magnetic resonance imaging machines). Moreover, disentangling the effects of private and public spending on health outcomes is a challenging task (see \[[@CR17]\]), and it is unclear how variations in the public financing of health care influence a country's health outcomes (see \[[@CR6]\]). Not all of the public expenditure on health has a measurable effect on health outcomes (e.g., the effect of the expenditure on tooth cleaning). Furthermore, we face the problem of differentiating between health expenditure and consumption (e.g., designer and basic spectacles).

Nonfinancial health care resources often used in the literature include practicing physicians and nurses and inpatient beds per 1000 population. Moreover, to take into account health care technology, technical equipment such as MRI units is considered medical input (see \[[@CR1]\]). Medical services such as surgeries and transplantations are not usually considered in research, but are assumed to be highly relevant to health care efficiency.

Due to issues with availability and missing data, we cannot cover all of the aspects of the ideal-typical inputs mentioned above. We categorize the inputs used into the three broad categories of basic medical inputs, intermediate medical inputs (accomplishments, provided services), and financial inputs:Basic medical inputshosp_beds: total hospital beds per 1000 populationphysicians: practicing physicians per 1000 populationnurses: practicing nurses per 1000 population.Intermediate medical inputs (used as outputs)cataract: cataract surgery, total number of procedures per 100,000 populationbypass: coronary artery bypass graft, inpatient cases per 100,000 populationkidney: transplantation of kidney, total number of procedures per 100,000 population.Financial inputshealthgdp: health expenditure as a share of gross domestic producthealthspend: total health expenditure per capita in USA dollars based on PPP.

### Outputs {#Sec12}

Unfortunately, the ideal (or almost ideal)-typical output measures that have already been mentioned are not available in health data sets. Life expectancy and infant mortality are often used as health output indicators, but these outputs are, of course, incomplete measures of health status since they do not reflect the quality of life of the living. Life expectancy depends strongly on social, cultural, and environmental factors (especially at the time of birth). Infant mortality strongly depends on health-system and hygiene standards but focuses on a very specific aspect of health. In addition, life expectancy and mortality rates are probably affected by country-specific rates of accidents, homicides, and suicides. It is difficult to define health care outcomes in the same way for all countries using a single factor, because different countries have different policy priorities and aims (see \[[@CR17]\]). Research shows that there are strong differences in the extent to which the health system influences performance measures, ranging from large effects on measures such as waiting time to very small effects on mortality, which is strongly influenced by factors that are not within the purview of the health care system (see \[[@CR18]\]). High infant mortality rates (e.g., in the USA) may be due to factors such as poverty rather than low health care system efficiency (see \[[@CR1]\]). To account for mortality rates that are less strongly affected by these factors, we include 30-day mortality after ischemic stroke and acute myocardial infarction in our analyses.

We categorize the output indicators into two groups: specific outputs and unspecific outputs. While recognizing that this distinction is somewhat fuzzy, we regard the specific outputs as more closely related to the effects of the health system than the unspecific outputs. For instance, infant mortality depends crucially on the hygiene standards applied and the medical care provided during birth. This is not true of general life expectancy, which is a weighted average of the number of deaths in a given year across all ages. Therefore, the living conditions and health provision across a period of about 100 years determine the actual measure of life expectancy. This means that life expectancy can, at best, be only partially attributed to the present state of the health system. We use the following variables for our analyses:Specific outputsinfmort: infant mortality, deaths per 1000 live birthsischemicstroke30: 30-day mortality after admission to hospital for ischemic stroke per 100 patients (based on admission data).amim30: 30-day mortality after admission to hospital for acute myocardial infarction (AMI) per 100 patients (based on admission data).Unspecific outputslifeexp: life expectancy at birth.

### Economic Conditions and Lifestyle {#Sec13}

It is not easy to correlate health status with the activities performed by health care systems. There are other non-health variables that are outside the range of influence of the health care system but can affect health, such as environmental conditions (e.g., temperature, pollution), socioeconomic factors (e.g., education, income, employment), and health-related behaviors and lifestyle (e.g., alcohol and tobacco consumption, hygiene) of the population. But these factors are not routinely measured and they are highly correlated with each other. For instance, many behavioral factors are correlated with educational attainment (see \[[@CR3]\]) and measures of income. Therefore, we face the problem of using a combination of macro (e.g., education, employment) and intermediate (e.g., smoking, alcohol) factors in the DEA model which could lead to biased results (see \[[@CR11]\]). We categorize the analyzed variables into economic conditions and lifestyle inputs:Economic conditionsgdp_ppp: GDP per capita in US dollars, based on PPPgini: Gini coefficient of income distribution (disposable income after taxes and transfers).Lifestyle inputalcohol: alcohol consumption in liters per capita, population aged 15+tobacco: % of population aged 15+ who are daily smokersobesity: % of population aged 15+.

Methodology {#Sec14}
-----------

Unfortunately, a large number of values are missing from the OECD health data. An all-encompassing analysis would only be possible for an extremely small number of countries. Thus, we instead focus on several aspects of health systems and conduct five partial analyses, as displayed in Fig. [3](#Fig3){ref-type="fig"}. Note that the analyses differ in the number of countries they consider. Moreover, we assume that separate analyses of specific aspects of health care provision are useful for providing detailed information on how a country's health care system works.Fig. 3Five partial analyses. *GDP* gross domestic product, *Pop.* population, *HExp* health expenditure

The first analysis (analysis I) focuses on the efficiency of surgery provision. Outputs are cataract and bypass surgeries and kidney transplantations (per 100,000 population). We use the numbers of physicians, nurses, and beds (per 1000 population) as medical inputs.

In the second analysis (analysis II), we focus on the efficiency of mortality prevention, defined by infant mortality, mortality 30 days after stroke, and mortality 30 days after infarct. Medical inputs are again the numbers of physicians, nurses, and beds (per 1000 population).

The third analysis (analysis III) concentrates on the effects of lifestyle on life expectancy from birth. Alcohol consumption, smoking, and obesity are used as lifestyle inputs.

The focus of the fourth analysis (analysis IV) is on the effects of income and health expenditure on life expectancy from birth. Income is measured as the gross domestic product per capita (GDP/Pop.). Expenditure is measured as the health expenditure per capita (HExp/Pop.).

In the fifth analysis (analysis V), we concentrate on the effects of relative expenditure, measured as the ratio of health expenditure to GDP (HExp/GDP), and inequality, measured as the Gini coefficient, on life expectancy from birth.

We use an input-oriented data envelopment analysis (DEA), as described in Sect. [2](#Sec2){ref-type="sec"}, with constant returns to scale. The idea of DEA is that price vectors are selected for each unit that maximize efficiency given a set of constraints, i.e., DEA provides the "optimal" price vectors $\documentclass[12pt]{minimal}
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Empirical Results {#Sec15}
=================

In the following, we present results for the five analyses separately. The tables provide information on the inputs and outputs used, the relative inputs and outputs (measured as the ratio of the country's weighted (by the mean input/output prices) sum of inputs/outputs and the maximum inputs/outputs of any country), the DEA efficiency scores, as well as the relative productivity of each country, based on the mean of the country-specific optimal prices across all countries. Relative productivity is by definition normalized to the interval \[0, 1\] and is therefore easily interpretable.[1](#Fn1){ref-type="fn"} Note that the average implicit weights in the last row of each of the following tables refer to the scaled variables, and---for ease of interpretation---we also provide the original input and output values in the tables.

We observe that the optimal prices for inputs and outputs vary considerably across countries, with several prices being zero. This fact is discussed by Lauer et al. \[[@CR22]\], who criticize the fact that a country can greatly increase its efficiency score by assigning zero weights to inputs and/or outputs it is not performing well in.

Analysis I: Surgeries {#Sec16}
---------------------

Table [2](#Tab2){ref-type="table"} shows the results for analysis I, comparing the efficiency of surgery provision.[2](#Fn2){ref-type="fn"} According to the DEA efficiency scores for each of the 19 considered countries, we find 7 countries to be efficient (score of 1): Belgium, Canada, Estonia, Hungary, Korea, Spain, and Sweden. Very inefficiently performing countries are Lithuania (0.649), New Zealand (0.652), and Germany (0.658); for instance, Lithuania could potentially reduce its inputs by 35.1% but still achieve its current output.

The measure of relative productivity reveals Hungary to be the most productive country (1.000), followed by Estonia (0.979), and Korea (0.932). We observe low productivities for New Zealand (0.227) and Denmark (0.370). Comparing the DEA efficiency score with the relative productivity reveals, for the majority of countries, a strong divergence between both measures, with the latter being considerably lower than the former. For example, for Sweden and the UK, the relative productivity is about half the DEA efficiency score (with country-specific input prices strongly diverging from the mean prices). Therefore, variations in input and output prices appear to have a strong impact on the productivity and efficiency values of the countries considered (see also \[[@CR22]\]). The correlation between DEA score and relative productivity based on average prices is 0.61. These results indicate that in DEA, countries emphasize their strengths and ignore aspects of health provision at which they are poor performers.Table 2Analysis I: medical inputs and surgeriesBedsPhys.NursesCatar.BypassKidneyRel.inp.Rel.outp.Eff.Rel.prod.Austria5.4604.9007.83011.2500.4350.0490.4880.9890.8650.819Belgium3.9902.9309.51010.9210.6440.0490.5861.0001.0000.690Canada1.7102.4809.35010.5310.5610.0380.5740.9531.0000.670Czech Republic4.5603.6708.06010.3990.5010.0410.4990.9320.8340.754Denmark2.5303.62016.3009.7990.6790.0471.0000.9160.8460.370Estonia3.5503.2806.17010.7340.3270.0450.3830.9281.0000.979Finland2.9203.01014.1209.5380.4720.0360.8660.8570.7620.400Germany5.3803.96012.6109.6430.6840.0320.7770.9030.6580.470Hungary3.9803.0906.3209.9690.9100.0300.3920.9701.0001.000Israel1.8903.2504.8205.4160.3720.0230.3000.5050.8870.680Korea6.1202.0804.8408.4170.0660.0360.3010.6931.0000.932Lithuania5.3804.2207.5905.3140.6210.0280.4720.5420.6490.464Luxembourg3.9602.78011.9209.6180.4650.0000.7320.8590.8150.474New Zealand2.6102.7009.9703.2700.4370.0240.6130.3440.6520.227Poland4.3202.2305.5603.4800.5460.0260.3440.3810.9350.447Slovenia3.6202.5408.1608.9140.4060.0110.5030.7930.8600.637Spain2.3003.8205.2406.1160.1770.0550.3270.5291.0000.654Sweden1.9504.01011.1509.3910.3460.0450.6870.8231.0000.484UK2.3102.7508.2106.1980.2870.0400.5060.5540.9420.443Mean3.6073.2278.8288.3640.4700.0340.5450.7620.8790.610Impl. pr.0.0450.2708.5890.0690.1540.060*Phys.* physicians, *Catar.* cataract, *Eff.* efficiency, *Prod.* productivity

Analysis II: Mortality {#Sec17}
----------------------

Table [3](#Tab3){ref-type="table"} presents the results for analysis II, focusing on the efficiency of mortality prevention. We find 6 out of the 22 considered countries to be efficient: Canada, Finland, Israel, Korea, Slovenia, and Sweden. Canada, Korea, and Sweden were also identified as efficient in the first analysis. Very inefficient are Austria (0.624), again Germany (0.645), and Mexico (0.403), which is an obvious outlier. A closer look at the used (relative) inputs and outputs reveals low input and a very low output in Mexico. We find that efficient countries achieve their efficiency in rather different ways; for example, by investing a medium quantity of input but producing comparably high output (e.g., Canada) or by investing a high quantity of input and producing very high output (e.g., Sweden). This fact is also mentioned by Afonso and Aubyn \[[@CR8]\].

The measures of relative productivity reveal Israel to be the most productive country (1.000), followed by Spain (0.788), Korea (0.771), and Canada (0.762). As also seen in analysis I, we observe some divergence between the DEA efficiency score and the relative productivity for most countries, with the latter again being considerably lower than the former. Despite the marked differences between the values of these measures, the correlation between DEA score and relative productivity based on average prices is actually rather strong (0.77).Table 3Analysis II: medical inputs and mortalityBedsPhys.NursesInfmortStroke30Ami30Rel. inpRel.outp.Eff.Rel.prod.Australia3.3603.31010.2205.2273.8305.9840.7430.8590.8460.623Austria5.4604.9007.8305.2694.6434.7490.9220.8990.6240.525Belgium3.9902.9309.5105.0153.8585.3330.7410.8290.8140.603Canada1.7102.4809.3504.5933.5505.4680.5510.7781.0000.762Czech Republic4.5603.6708.0605.5223.8025.4450.7870.8580.7560.588Denmark2.5303.62016.3005.1843.9155.5570.8830.8510.7710.520Estonia3.5503.2806.1705.1002.7944.4570.6370.7090.8410.600Finland2.9203.01014.1205.6074.9235.3780.8070.9651.0000.645Germany5.3803.96012.6105.2274.5874.9740.9940.8980.6450.487Iceland2.2903.57015.1606.1564.2235.4230.8300.9360.9910.607Israel1.8903.2504.8205.1004.4475.5350.4820.8951.0001.000Japan7.9402.29010.5405.6915.6244.2331.0001.0000.9580.539Korea6.1202.0804.8405.3965.5125.0190.6960.9951.0000.771Luxembourg3.9602.78011.9205.5653.9155.4000.7990.8700.9140.587Mexico1.5302.1202.5501.0001.0001.0000.3180.1850.4030.313New Zealand2.6102.7009.9704.4234.0835.4450.6450.8160.9500.682Norway2.3404.23016.5305.5654.8955.3100.9170.9580.8790.563Slovenia3.6202.5408.1605.9452.7665.5350.6510.7911.0000.655Spain2.3003.8205.2405.3113.6065.1530.5600.8180.9550.788Sweden1.9504.01011.1505.5224.7835.9610.7190.9651.0000.723Switzerland2.9903.92016.9705.1004.5315.2430.9540.8930.7740.505UK2.3102.7508.2104.8883.6625.1980.5760.7990.9520.747Mean3.4233.23710.0105.1094.0435.0820.7370.8440.8670.629Impl. pr.0.0760.0730.0320.1010.1520.050*Phys.* physicians, *Infmort* infant mortality, *Stroke30* 30-day mortality after admission to hospital for ischemic stroke per 100 patients, *Ami30* 30-day mortality after admission to hospital for acute myocardial infarction per 100 patient, *Eff.* efficiency, *Prod.* productivity

Analysis III: Lifestyles {#Sec18}
------------------------

Results for analysis III, focusing on the effects of different lifestyles on life expectancy, are summarized in Table [4](#Tab4){ref-type="table"}. Here, we observe 16 countries, 5 of which are identified as efficient: Estonia, Luxembourg, Mexico, UK, and the United States. Very low efficiency scores are recorded for Japan (0.580), Sweden (0.626), and Norway (0.643). Interestingly, Sweden was found to be efficient in the first two analyses and Mexico to be substantially inefficient in analysis II. A closer look at inputs and outputs indicates that Mexico is characterized by the highest percentage of obesity in the population, but life expectancy is sufficient for it to be characterized as an efficient country.

Based on the relative productivity, we again find Sweden (0.543), Japan (0.565), and Norway (0.591) to perform rather inefficiently. The highest productivity is reported for Estonia (1.000), followed by the UK (0.911). Again, we observe some differences between DEA efficiency scores and relative productivity values; the correlation between DEA score and relative productivity is 0.78. For Mexico, we observe a large difference between scores based on country-specific prices and on mean prices. While Mexico is regarded as efficient according to its DEA score, its efficiency in terms of relative productivity is below average.Table 4Analysis III: lifestyle inputs and life expectancyAlcoholTobaccoObeseLifexpRel. inpRel.outp.Eff.Rel.prod.Canada8.10016.10050.90081.4500.8520.9800.7100.635Estonia12.20027.25048.90076.4500.5080.9191.0001.000Finland9.30017.45049.40080.7000.8200.9710.7480.654France11.70024.45044.40082.0500.6450.9870.9220.845Japan7.20021.55023.70083.1500.9771.0000.5800.565Luxembourg11.30016.80059.20081.4500.7260.9801.0000.745Mexico5.70012.30071.30074.3500.7640.8941.0000.647Netherlands9.10018.45047.90081.1500.8060.9760.7380.669New Zealand9.20016.50063.80081.1500.6970.9760.9670.774Norway6.20016.00046.00081.5000.9160.9800.6430.591Slovenia11.00020.50056.90080.2000.6380.9650.9880.836Sweden7.30012.75047.10081.7501.0000.9830.6260.543Switzerland9.90020.45041.00082.7500.8140.9950.7320.676Turkey1.60024.00052.00074.6000.6270.8970.8870.791UK9.70020.50061.90080.9500.5910.9741.0000.911USA8.80014.20068.60078.8000.7190.9481.0000.729Mean8.64418.70352.06280.1530.7560.9640.8460.726Impl. pr.0.0110.1090.1020.224*Lifexp* life expectancy at birth, *Eff.* efficiency,*Prod*.: productivity

Analysis IV: Per Capita Income and Health Care Spending {#Sec19}
-------------------------------------------------------

In the fourth analysis (Table [5](#Tab5){ref-type="table"}), investigating the efficiency of income and health expenditure per capita, we observe only Mexico and Turkey to be efficient among the 30 countries considered. Luxembourg (0.222), Norway (0.278), Switzerland (0.335), and the USA (0.346) are characterized as very inefficient countries. All of these countries use high input quantities (primarily GDP for Luxembourg, health expenditure for USA), which is not sufficiently reflected in their life expectancies. Interestingly, the efficient countries Mexico and Turkey provide very low input and produce low output. This indicates that increased absolute health spending and income per capita have only moderate effects on life expectancy.

Based on the relative productivity, Mexico is the most productive country (1.000), followed by Turkey (0.943) and Chile (0.829). Countries with a low relative productivity are again Luxembourg (0.201) and Norway (0.276). The correlation between both efficiency measures is close to 1.Table 5Analysis IV: absolute expenditure/income and life expectancyHspendGdpLifexpRel. inpRel.outp.Eff.Rel.prod.Austria4.52844.87381.0000.4960.9740.4080.404Belgium4.22541.39780.4500.4570.9680.4390.435Canada4.30442.12881.4500.4650.9800.4370.432Chile1.47621.41278.7000.2340.9460.8310.829Czech Republic2.02128.64378.1500.3140.9400.6170.615Denmark4.51243.56080.1000.4810.9630.4160.411Estonia1.34124.73576.4500.2700.9190.7250.700Finland3.40340.20980.7000.4420.9710.4540.451France4.04537.45682.0500.4140.9870.4950.489Germany4.69343.52380.9500.4820.9740.4200.415Hungary1.69722.49475.1500.2470.9040.7550.752Ireland3.66345.24280.9500.4970.9740.4040.402Israel2.12731.62981.7500.3460.9830.5840.583Italy3.13735.52582.3000.3910.9900.5240.520Japan3.59235.61183.1500.3931.0000.5280.522Korea2.14232.02281.2500.3500.9770.5740.573Luxembourg4.37191.85081.4501.0000.9800.2220.201Mexico1.02616.80874.3500.1840.8941.0001.000Netherlands5.08146.05481.1500.5100.9760.3980.393Norway5.82366.36381.5000.7300.9800.2780.276Poland1.44823.15276.8500.2530.9240.7500.750Portugal2.52327.00080.4500.2980.9680.6740.668Slovak Republic1.97725.71876.2000.2820.9160.6700.667Slovenia2.48328.45080.2000.3130.9650.6370.633Spain2.95732.77082.5000.3610.9920.5690.565Sweden4.74343.86981.7500.4850.9830.4210.416Switzerland6.14055.91682.7500.6190.9950.3350.330Turkey0.89017.93574.6000.1950.8971.0000.943UK3.17537.38680.9500.4110.9740.4890.486USA8.45451.49678.8000.5780.9480.3460.337Mean3.40037.84179.9350.4170.9610.5470.540Impl. pr.0.0070.0250.029*Hspend* total health expenditure per capita in US dollars based on purchasing power parity, *Gdp* gross domestic product per capita in US dollars based on purchasing power parity, *Lifexp* life expectancy at birth, *Eff.* efficiency, *Prod.* productivity

Analysis V: Relative Health Care Spending and Inequality {#Sec20}
--------------------------------------------------------

Analysis V focuses on the efficiency of relative health expenditure and inequality. Results for the 27 countries are presented in Table [6](#Tab6){ref-type="table"}. Resembling the results of analysis IV, only two countries have an efficiency score of 1: Mexico and Turkey. The next most efficient countries are Israel (0.950) and the USA (0.943). In general, efficiency scores are close to 1; the lowest score of 0.765 is reported for the Slovak Republic. Mexico as well as Turkey report high Gini coefficients and low life expectancies. As income inequality has a negative but rather indirect effect on life expectancy, we find that the ultimately negative effect of high inequality (e.g., in Mexico) is not reflected in an accordingly low life expectancy.

Relative productivity is lowest for the Slovak Republic (0.742). Mexico has the highest relative productivity (1.000), followed by Israel (0.949) and the USA (0.942). We observe only small differences between DEA efficiency scores and relative productivity, and a very strong correlation between both efficiency measures (0.92).Table 6Analysis V: healthcare expenditure/GDP, Gini, and life expectancyHgdpGiniLifexpRel. inpRel.outp.Eff.Rel.prod.Austria0.1010.27681.0000.9640.9790.8170.817Belgium0.1020.26880.4500.9750.9720.8030.803Czech Republic0.0710.25678.1500.9900.9440.8100.767Denmark0.1040.24980.1001.0000.9680.7790.779Estonia0.0570.33876.4500.8810.9240.9170.844Finland0.0850.26080.7000.9850.9750.7960.796France0.1080.30682.0500.9240.9920.8630.863Germany0.1080.28980.9500.9470.9780.8320.831Hungary0.0750.28975.1500.9470.9080.7870.772Ireland0.0810.30480.9500.9270.9780.8490.849Israel0.0700.37181.7500.8370.9880.9500.949Italy0.0880.32782.3000.8960.9950.8930.893Korea0.0670.30781.2500.9230.9820.8990.856Luxembourg0.0660.30281.4500.9290.9840.9000.852Mexico0.0610.45774.3500.7230.8981.0001.000Netherlands0.1100.28181.1500.9570.9810.8240.824Norway0.0880.25381.5000.9950.9850.7970.797Poland0.0630.29876.8500.9340.9290.8600.800Portugal0.0930.33880.4500.8820.9720.8880.887Slovak Republic0.0770.25076.2000.9980.9210.7650.742Slovenia0.0870.25080.2000.9990.9690.7810.781Spain0.0900.33582.5000.8850.9970.9060.906Sweden0.1080.27481.7500.9670.9880.8220.822Switzerland0.1100.28582.7500.9521.0000.8450.845Turkey0.0500.40274.6000.7960.9021.0000.911UK0.0850.35180.9500.8640.9780.9110.911USA0.1640.39078.8000.8130.9520.9430.942Mean0.0880.30879.8060.9220.9640.8610.846Impl. pr.0.0111.5481.305*Hgdp* health expenditure as share of gross domestic product, *Gini* Gini coefficient, *Lifexp* life expectancy at birth, *Eff.* efficiency, *Prod.* productivity

Synopsis {#Sec21}
--------

Table [7](#Tab7){ref-type="table"} in the Appendix provides an overview of the DEA scores obtained in all five analyses of 34 countries. The mean is calculated on the basis of 1--5 DEA efficiency scores, and the ranking is based on the mean. We observe Iceland to be the most efficient country, followed by Turkey and Estonia. The lowest mean efficiency scores are reported for Ireland and Germany.

Efficiency scores vary strongly across the five analyses, with some countries performing efficiently in one or more analyses and very inefficiently in others (e.g., Mexico, Canada, and Sweden). Therefore, countries can indeed be efficient at producing specific health care outputs and inefficient at producing others. For example, Mexico is identified as efficient at producing life expectancy, due to its very low input, but inefficient at preventing mortality. This result emphasizes the value of disaggregated analysis, as a combined analysis would probably mask important specific inefficiencies.

We observe for some countries that financial inputs could be strongly reduced without degrading the current output. The potential increase in output with improvements in lifestyle inputs is much lower. For example, for Canada, we find that there is great potential to reduce financial inputs (GDP per capita, health expenditure per capita) without negatively impacting life expectancy, but a lower potential to reduce lifestyle inputs. Also, for Austria, we observe great potential to reduce medical inputs for mortality, but not to reduce inputs for surgeries.

Conclusions {#Sec22}
===========

In this study, we investigated the efficiencies of the health care systems of various OECD countries based on OECD health data. We focused on specific aspects of the health care systems and conducted five separate partial analyses investigating the effiects of medical inputs on surgery provision, medical inputs on mortality prevention, lifestyle on life expectancy from birth, income and health expenditure per capita on life expectancy from birth, and health expenditure relative to GDP and income equality on life expectancy from birth.

We applied an input-oriented data envelopment analysis (DEA) assuming constant returns to scale. DEA provides optimal input and output weights for each country, maximizing each country's efficiency, given a set of constraints. The obtained optimal weights of the linear problem in multiplier form varied strongly among countries, with several input and output prices being 0, pointing to slacks.

Since DEA allows countries to emphasize the importance of specific inputs and outputs, allowing the efficiency to be exaggerated, we also used average prices for aggregation and constructed an alternative measure of relative productivity. Economically, zero weights are dubious, as the DEA scores then rest on dubious assumptions; for instance, that beds and physicians in Denmark and in the UK are costless (analysis I). The measure of relative productivity is therefore more informative if all countries face rather similar input prices. The correlation between DEA score and relative efficiency differed across the five analyses but was generally rather strong.

We observed efficiency scores to vary substantially across the five analyses, with some countries being efficient in one or more analyses and very inefficient in others. Therefore, countries were found to be efficient at producing specific health care outputs but very inefficient at producing others. Furthermore, we found that efficient countries could achieve their high efficiencies in several ways. The rankings of the 34 considered countries, based on the mean of 1--5 efficiency scores, revealed that Iceland was the most efficient country, followed by Turkey and Estonia. The lowest ranking were obtained for Ireland and Germany.

Inefficient countries have to decide whether to focus on input reduction or output improvement to become more efficient. The benchmark country chosen as a reference when making this decision will depend on the preferences of the country that is making this choice. Our individual analyses allowed us to identify, for each country, which of the outputs/inputs had the greatest potential to be increased/reduced to obtain efficiency gains.

In analysis I (medical inputs and surgeries), we found that Germany was inefficient at producing surgeries. A closer look at inputs and outputs for Germany revealed that that its utilization of about $\documentclass[12pt]{minimal}
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                \begin{document}$$90\%$$\end{document}$ of the maximum output (as produced by the efficient country of Belgium). As Germany is a rather rich country, it would probably be more logical to increase output to the highest observed level rather than reducing inputs. A comparison with Belgium, the relevant benchmark country, reveals that Germany produces far fewer kidney transplantations and cataract surgeries. Therefore, more efficient organization of transplantations would increase Germany's health care system efficiency in this specific aspect. According to this reasoning, Spain---which also belongs to the reference set---would probably be less suitable for use as a benchmark due to its comparatively low output.

On the other hand, Denmark is the country with the highest sum of weighted inputs in most analyses, so it could focus on reducing inputs rather than on further increasing its already high output. Looking at the inputs reveals that there is great potential to reduce the number of practicing nurses, which is very high compared to all other countries. But, of course, the route to improving Danish health care efficiency depends on the preferences of the Danish population or its representatives.

Again using Germany as example, analysis II (medical inputs and mortality) revealed that there is high potential to increase outputs in order to become efficient. Using Japan---the country with the highest sum of outputs---as a benchmark, Germany has considerable potential to reduce its 30-day mortality after admission to hospital for ischemic stroke. But, as Germany is also the country with the second highest use of inputs, there is also great potential for input reduction (particularly beds and nurses, which are well above average). Austria, which has very similar efficiency measures and similar relative inputs and outputs to Germany, has the greatest potential to reduce beds and physicians to increase efficiency.

In analysis III (lifestyle and mortality), we observed that Japan was the most inefficient country despite presenting the highest output. Japan uses a very high amount of weighted inputs, which, in the case of "bad" inputs, means that there is low alcohol and tobacco consumption as well as low obesity in Japan. As increasing these inputs is not realistic policy advice, Japan would have to increase its average life expectancy---which is already the highest in the world---to become more efficient. But the fact that many countries with rather unhealthy lifestyles have above-average live expectancies (e.g., France and the UK) indicates that lifestyle is a relatively minor determinant (among many others) of life expectancy.

The results of analysis IV (absolute expenditure/income and life expectancy) hinted strongly that absolute income and health spending per capita have no proportional effect on life expectancy. Some high-income and high-spending countries have extremely low efficiency scores (Luxembourg, Norway, Switzerland, and the USA). For instance, life expectancy in Switzerland is 99.5% of the highest observed value (for Japan), but the efficiency score for Switzerland is only 0.335. As reducing GDP is not a meaningful option for policymakers to increase the efficiency of the health care system, there is probably only some potential to decrease health expenditure. Similar arguments hold for analysis V (relative spending/inequality and life expectancy), as we again observed only very moderate effects of relative health care spending and equality on life expectancy.

Summing up, we found that analyses I and II hinted much more strongly at possible policy recommendations than analyses III--V did. We also agree with Medeiros and Schwierz \[[@CR14]\], who conclude that for countries with already high life expectancies, focusing on inputs seems to be a more relevant path for policymakers.

We conclude that performing separate analyses of specific aspects of health care provision is a useful approach for shedding light on how a country's health care system works in detail. It provides important information that can be used to pinpoint where policy interventions should be focused to improve specific parts of a country's health care system.

Appendix {#Sec23}
========

See Tables [7](#Tab7){ref-type="table"} and [8](#Tab8){ref-type="table"}. Table 7Overview: DEA scoresCountrye1e2e3e4e5MeanRankAustralia0.8460.84613.0Austria0.8650.6240.4080.8170.67828.0Belgium1.0000.8140.4390.8030.76419.0Canada1.0001.0000.7100.4370.78715.0Chile0.8310.83114.0Czech Republic0.8340.7560.6170.8100.75422.0Denmark0.8460.7710.4160.7790.70326.0Estonia1.0000.8411.0000.7250.9170.8973.0Finland0.7621.0000.7480.4540.7960.75223.0France0.9220.4950.8630.76021.0Germany0.6580.6450.4200.8320.63933.0Hungary1.0000.7550.7870.84712.0Iceland0.9910.9911.0Ireland0.4040.8490.62634.0Israel0.8871.0000.5840.9500.8558.0Italy0.5240.8930.70825.0Japan0.9580.5800.5280.68927.0Korea1.0001.0000.5740.8990.8684.0Lithuania0.6490.64931.5Luxembourg0.8150.9141.0000.2220.9000.77018.0Mexico0.4031.0001.0001.0000.85110.0Netherlands0.7380.3980.8240.65330.0New Zealand0.6520.9500.9670.8567.0Norway0.8790.6430.2780.7970.64931.5Poland0.9350.7500.8600.84811.0Portugal0.6740.8880.78116.0Slovak Republic0.6700.7650.71824.0Slovenia0.8601.0000.9880.6370.7810.8539.0Spain1.0000.9550.5690.9060.8576.0Sweden1.0001.0000.6260.4210.8220.77417.0Switzerland0.7740.7320.3350.8450.67229.0Turkey0.8871.0001.0000.9622.0UK0.9420.9521.0000.4890.9110.8595.0USA1.0000.3460.9430.76320.0 Table 8Literature overview: OECD dataPaperDataInputsOutputsMethodsResultsRetzlaff-Roberts et al. \[[@CR1]\]OECD health data (2000), 27 countriesEnvironment: school expectancy, Gini coefficient, tobacco use; healthcare: practicing physicians, inpatient beds, MRI, share of GDP allocated to health careInfant mortality, life expectancy at birthDEA (input- and output-oriented, VRS), each output individually, both outputs13 countries are efficient in relation to both outputs (Australia, Canada, France, Greece, Ireland, Japan, Korea, Mexico, Norway, Spain, Sweden, Turkey, UK), 8 countries are inefficient in relation to both outputs (Austria, Belgium, Germany, Hungary, Netherlands, New Zealand, Switzerland, USA), a country can be technically efficient/inefficient at any level of health outcomeBhat \[[@CR7]\]OECD health data (2002, 2003), 24 countriesPracticing physicians, nurses, inpatient beds, pharmaceuticalsPopulation aged 0-19 years; population aged 20-64 years; population aged 65 years and olderDEA (CRS)8 efficient countries (Denmark, Japan, Netherlands, Norway, Portugal, Sweden, Turkey, UK), lowest efficiency: Belgium, Iceland, AustraliaAfonso and Aubyn \[[@CR8]\]OECD health data (2002), 24 countriesNumber of doctors, nurses, inpatient bedsInfant survival rate, life expectancyFree disposable hull (FDH), DEA (input- and output-oriented, VRS, CRS)Under FDH and DEA: 8 countries are efficient (Canada, Japan, Korea, Portugal, Spain, Sweden, UK, USA)Afonso and Aubyn \[[@CR9]\]OECD health data (2005), 19 (21) countriesNumber of practicing physicians, nurses, acute care beds (per 1000), MRI; (nondiscretionary: GDP per capita, educational level, obesity, tobacco consumption)Infant survival rate, life expectancy, potential years of life not lostTwo stages: DEA (output-oriented, VRS), (truncated) regression analysis (bootstrapping), PCA7 efficient countries ( Canada, Finland, Japan, Korea, Spain, Sweden, USA), a 40% increase in output is possible on averageAdang \[[@CR10]\]OECD health data, 1995--2000/2002, Eurobarometer surveyShare of GDP allocated to health care, number of practicing physicians, tobacco useLife expectancy at birth, infant mortalityDEA (output-oriented, CRS), Malmquist indexNo association between economic performance of health care system and change in satisfaction with health care systemSpinks and Hollingsworth \[[@CR11]\]OECD health data (2004), 1995, 2000, 28 countries; WHO dataSchool expectancy years, unemployment rate, GDP per capita, health expenditure per capitaLife expectancy at birthDEA (input-oriented, BCC), Malmquist index1995: 6 efficient countries (Turkey, Mexico, Korea, Greece, Spain, Japan); 2000: 8 efficient countries (Turkey, Mexico, Korea, Greece, Spain, Japan, Iceland, Switzerland)

Tables with implicit DEA prices for the used inputs and outputs are available upon request.

We used the R programming environment throughout. The efficiency analysis was carried out using the simplex function provided in the boot package.
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